SCHEMBL5067228

SCHEMBL5067228

Nc1ncn([C@H]2C[C@H](O)[C@@H](COC(=O)OCCc3ccc([N+](=O)[O-])cc3)O2)c(=O)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 2/20 0.53
ADRB1 P08588 1/20 0.53
SLC29A1 Q99808 2/20 0.43
TYMS P04818 1/20 0.41
POLB P06746 2/20 0.39
NT5E P21589 2/20 0.37
HBB P68871 2/20 0.36
CYP1A2 P05177 1/20 0.36
P2RY2 P41231 1/20 0.36
P2RY4 P51582 1/20 0.36
P2RY6 Q15077 1/20 0.36
LMNA P02545 2/20 0.36
RAB9A P51151 2/20 0.36
CYP3A4 P08684 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GMNN O75496 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7646628 0.88 POLB (0.51) DNMT1ADRB1SLC29A1TYMSPOLB
SCHEMBL7644531 0.83 SLC29A1 (0.56) SLC29A1POLBNT5E
SCHEMBL1152839 0.80 SLC29A1 (0.51) DNMT1ADRB1SLC29A1TYMSHBB
SCHEMBL1152834 0.80 SLC29A1 (0.51) DNMT1ADRB1SLC29A1TYMSHBB
SCHEMBL10064053 0.77 DNMT1 (0.70) DNMT1ADRB1POLBNT5EHBB
SCHEMBL19283452 0.74 DNMT1 (0.76) DNMT1ADRB1POLBNT5EHBB
SCHEMBL7643482 0.74 P2RY2 (0.38) SLC29A1TYMSPOLBNT5EP2RY2
SCHEMBL7027958 0.74 POLB (0.57) SLC29A1TYMSPOLBNT5EHBB
SCHEMBL10064225 0.74 DNMT1 (0.74) DNMT1ADRB1POLBNT5EHBB
SCHEMBL16366026 0.74 DNMT1 (0.74) DNMT1ADRB1POLBNT5EHBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234223-A1 N4 MODIFICATIONS OF PYRIMIDINE ANALOGS AND USES THEREOF UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234223-A1 N4 MODIFICATIONS OF PYRIMIDINE ANALOGS AND USES THEREOF TYMP, TYMS, DPYD DNMT1 465/4885ADRB1 4599/4885SLC29A1 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.